Grant of Options

RNS Number : 8860A

Omega Diagnostics Group PLC

25 February 2014

 



Omega Diagnostics Group PLC

("Omega" or the "Company")

Grant of Options

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that its Remuneration Committee on 25 February 2014 awarded the following director share options:

		Options granted 25 February 2014		Total options following grant
Andrew Shepherd		800,000		2,103,480
Kieron Harbinson		640,000		1,408,987
Jag Grewal		610,000		910,000

All options are awarded under the Company's EMI Share Option Scheme. The options have a three year vesting period, have been awarded at an exercise price of 30.5p (closing mid-market price on 24 February 2014) and after they are fully vested, there is a performance criteria that they cannot be exercised until the share price is at 50p or higher.

Contacts:

Omega Diagnostics Group PLC	Tel: [phone]
Andrew Shepherd, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
Jag Grewal, Group Sales and Marketing Director
finnCap Ltd	Tel: [phone]
Geoff Nash/Christopher Raggett (Corporate Finance)
Stephen Norcross/Mia Gardner (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

RDSBBGDDLXDBGSU